Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children
Summary
- Eligibility
- for people ages 2-6 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Laya Ekhlaspour, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Laya Ekhlaspour, MD
I am a physician-scientist and an assistant Professor of Pediatrics at the University of California, San Francisco, and my research is focused on the use of technology in children with type 1 diabetes.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Medtronic Diabetes
- ID
- NCT06604871
- Study Type
- Interventional
- Participants
- Expecting 60 study participants
- Last Updated